VRDN 302- Non Responder
Enrolling By Invitation
99 years and younger
All
Phase
N/A
1 Location
Brief description of study
This study will investigate the safety and efficacy of VRDN-001 in participants who were non-responders as defined in either the VRDN-001-101 or VRDN-001-301 pivotal studies.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Updated on
01 Aug 2024.
Study ID: 855710
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
